Terminally modified, short phosphorothioate oligonucleotides as inhibitors of gene expression in cells
Phosphorothioates are excellent antisense inhibitors, which are active both in cells and in vivo. Since their affinity to complementary ribonucleic acids is rather low, long strands (⩾20-mers) are typically required to achieve the desired biological activity. However, mismatch discrimination of long...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
15 August 2014
|
| In: |
Bioorganic & medicinal chemistry letters
Year: 2014, Volume: 24, Issue: 19, Pages: 4694-4698 |
| ISSN: | 1464-3405 |
| DOI: | 10.1016/j.bmcl.2014.08.027 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.bmcl.2014.08.027 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0960894X14008580 
|
| Author Notes: | Paul Marzenell, Helen Hagen, Jenny Blechinger, Holger Erfle, Andriy Mokhir |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1725224364 | ||
| 003 | DE-627 | ||
| 005 | 20230426183658.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200721s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bmcl.2014.08.027 |2 doi | |
| 035 | |a (DE-627)1725224364 | ||
| 035 | |a (DE-599)KXP1725224364 | ||
| 035 | |a (OCoLC)1341346959 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Marzenell, Paul David |e VerfasserIn |0 (DE-588)1051115825 |0 (DE-627)785815341 |0 (DE-576)405858825 |4 aut | |
| 245 | 1 | 0 | |a Terminally modified, short phosphorothioate oligonucleotides as inhibitors of gene expression in cells |c Paul Marzenell, Helen Hagen, Jenny Blechinger, Holger Erfle, Andriy Mokhir |
| 264 | 1 | |c 15 August 2014 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.07.2020 | ||
| 520 | |a Phosphorothioates are excellent antisense inhibitors, which are active both in cells and in vivo. Since their affinity to complementary ribonucleic acids is rather low, long strands (⩾20-mers) are typically required to achieve the desired biological activity. However, mismatch discrimination of long inhibitors is reduced. In contrast, shorter phosphorothioates exhibit better sequence specificity, but have in most cases too low affinity for practical applications in cells. We screened a range of terminal modifiers of a 14-mer phosphorothioate sequence, which is complementary to mRNA of a representative gene, whose protein product is fluorescent (DsRed2) and easy to monitor in cells. We found that optimal combinations of 5′- and 3′-modifications include 5′-trimethoxystilbene with 3′-uracil(anthraquinone)-cap, 5′-chloic acid derivative with 3′-uracyl(anthraquinone)-cap and 5′-cholic acid derivative with three 3′-LNA moieties. In contrast to the LNA, stabilizing and activity-enhancing effects of other mentioned modifiers for PTO/RNA duplexes have not been previously reported. We observed that the 14-mer inhibitor carrying 5′-cholic acid derivative with three 3′-LNA moieties inhibits expression of DsRed2 in cells stronger than the unmodified 21-mer. Mismatch discrimination of this inhibitor was found to be comparable to that of the unmodified 14-mer. | ||
| 650 | 4 | |a Antisense | |
| 650 | 4 | |a Chemical modification | |
| 650 | 4 | |a Oligonucleotide | |
| 650 | 4 | |a Phosphorothioate | |
| 650 | 4 | |a Terminal modifier | |
| 700 | 1 | |a Hagen, Helen |e VerfasserIn |0 (DE-588)1043232052 |0 (DE-627)770438881 |0 (DE-576)394589599 |4 aut | |
| 700 | 1 | |a Blechinger, Jenny |e VerfasserIn |4 aut | |
| 700 | 1 | |a Erfle, Holger |e VerfasserIn |0 (DE-588)1033880965 |0 (DE-627)742725650 |0 (DE-576)184848008 |4 aut | |
| 700 | 1 | |a Mokhir, Andriy |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioorganic & medicinal chemistry letters |d Amsterdam [u.a.] : Elsevier Science, 1991 |g 24(2014), 19, Seite 4694-4698 |h Online-Ressource |w (DE-627)306717522 |w (DE-600)1501505-1 |w (DE-576)110916573 |x 1464-3405 |7 nnas |a Terminally modified, short phosphorothioate oligonucleotides as inhibitors of gene expression in cells |
| 773 | 1 | 8 | |g volume:24 |g year:2014 |g number:19 |g pages:4694-4698 |g extent:5 |a Terminally modified, short phosphorothioate oligonucleotides as inhibitors of gene expression in cells |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.bmcl.2014.08.027 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0960894X14008580 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200721 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 1033880965 |a Erfle, Holger |m 1033880965:Erfle, Holger |d 700000 |d 716000 |e 700000PE1033880965 |e 716000PE1033880965 |k 0/700000/ |k 1/700000/716000/ |p 4 | ||
| 998 | |g 1043232052 |a Hagen, Helen |m 1043232052:Hagen, Helen |p 2 | ||
| 998 | |g 1051115825 |a Marzenell, Paul David |m 1051115825:Marzenell, Paul David |p 1 |x j | ||
| 999 | |a KXP-PPN1725224364 |e 3726987967 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Marzenell","role":"aut","display":"Marzenell, Paul David","given":"Paul David"},{"display":"Hagen, Helen","role":"aut","family":"Hagen","given":"Helen"},{"given":"Jenny","role":"aut","family":"Blechinger","display":"Blechinger, Jenny"},{"display":"Erfle, Holger","family":"Erfle","role":"aut","given":"Holger"},{"family":"Mokhir","role":"aut","display":"Mokhir, Andriy","given":"Andriy"}],"note":["Gesehen am 21.07.2020"],"language":["eng"],"origin":[{"dateIssuedDisp":"15 August 2014","dateIssuedKey":"2014"}],"name":{"displayForm":["Paul Marzenell, Helen Hagen, Jenny Blechinger, Holger Erfle, Andriy Mokhir"]},"id":{"doi":["10.1016/j.bmcl.2014.08.027"],"eki":["1725224364"]},"recId":"1725224364","type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"5 S."}],"title":[{"title":"Terminally modified, short phosphorothioate oligonucleotides as inhibitors of gene expression in cells","title_sort":"Terminally modified, short phosphorothioate oligonucleotides as inhibitors of gene expression in cells"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Bioorganic & medicinal chemistry letters","subtitle":"a Tetrahedron publication for rapid dissemination of preliminary communications on all aspects of bioorganic chemistry, medicinal chemistry, bioinorganic chemistry and related disciplines","title":"Bioorganic & medicinal chemistry letters"}],"part":{"extent":"5","year":"2014","pages":"4694-4698","issue":"19","text":"24(2014), 19, Seite 4694-4698","volume":"24"},"titleAlt":[{"title":"Bioorganic and medicinal chemistry letters"}],"pubHistory":["1.1991 -"],"note":["Gesehen am 09.11.2020"],"language":["eng"],"recId":"306717522","id":{"eki":["306717522"],"zdb":["1501505-1"],"issn":["1464-3405"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Terminally modified, short phosphorothioate oligonucleotides as inhibitors of gene expression in cellsBioorganic & medicinal chemistry letters","origin":[{"dateIssuedDisp":"1991-","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1991","publisher":"Elsevier Science"}]}]} | ||
| SRT | |a MARZENELLPTERMINALLY1520 | ||